 Michele Tana, MD
|
| Title | Assistant Professor |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Medicine |
|---|
| Address | 1001 Potrero Ave
San Francisco CA 94110
|
|---|
| Phone | 415-206-8823 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | Harvard College | A.B. | 2000 | Classics | | Harvard University | M.D. | 2005 | Medical Schoool | | Duke University | M.H.S. | 2016 | Clinical Research | | Stanford University | Internal Medicine | 2008 | School of Medicine | | California Pacific Medical Center | Gastroenterology | 2011 | Department of Medicine | | National Institutes of Health | Hepatology | 2013 | NIDDK |
Overview Michele Tana grew up in Northern Virginia. She studied the Classics at Harvard College, then went to Harvard Medical School. She did her Internal Medicine training at Stanford University Hospital and Clinics and her gastroenterology fellowship at California Pacific Medical Center. She spent two years at the National Institutes of Health as a Clinical Fellow in the National Institute of Diabetes and Digestive and Kidney Diseases, Liver Diseases Branch, then joined the UCSF faculty at San Francisco General Hospital in 2013. She is a clinician-educator with an interest in clinical research.
alcoholic liver disease, autoimmune hepatitis, fatty liver disease, gastrointestinal endoscopy, health disparities, health services research, medical education, mentoring, patient reported outcomes, primary biliary cirrhosis, underserved populations, viral hepatitis
ORNG Applications Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana M. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Am J Gastroenterol. 2018 Feb; 113(2):243-253. PMID: 29380822.
-
-
Tana M, Muir AJ. Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue? Clin Gastroenterol Hepatol. 2018 Jan; 16(1):16-18. PMID: 28694131.
-
van Wijk XM, Magee CA, Wu AH, Tana M, Lynch KL. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clin Chim Acta. 2016 Dec 01; 463:1-3. PMID: 27732874.
-
Ha J, Yan M, Aguilar M, Bhuket T, Tana M, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer. 2016 08 15; 122(16):2512-23. PMID: 27195481.
-
Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol. 2016 May-Jun; 50(5):423-30. PMID: 26583267.
-
Tana M, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. Am J Clin Pathol. 2015 Oct; 144(4):601-6. PMID: 26386081.
-
Tana M, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015 May; 135(5):823-8. PMID: 25728497; PMCID: PMC4414791.
-
Tana M, Heller T. Autoantibodies in hepatitis C: red flag or bystander effect? J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):243. PMID: 23443062; PMCID: PMC3584299.
-
Tana M, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet. 2013 Feb 09; 381(9865):433-4. PMID: 23234726.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|
